Group One Trading’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-773
| Closed | -$16.7K | – | 8282 |
|
|
2022
Q4 | $16.7K | Buy |
773
+692
| +854% | +$14.6K | ﹤0.01% | 5715 |
|
|
2022
Q3 | $2K | Sell |
81
-200
| -71% | -$4.14K | ﹤0.01% | 7246 |
|
|
2022
Q2 | $6K | Buy |
281
+9
| +3% | +$237 | ﹤0.01% | 7066 |
|
|
2022
Q1 | $8K | Sell |
272
-2,139
| -89% | -$62.6K | ﹤0.01% | 7270 |
|
|
2021
Q4 | $56K | Sell |
2,411
-6,385
| -73% | -$170K | ﹤0.01% | 6245 |
|
|
2021
Q3 | $274K | Buy |
8,796
+1,387
| +19% | +$42.9K | ﹤0.01% | 4840 |
|
|
2021
Q2 | $261K | Buy |
7,409
+1,843
| +33% | +$59.9K | ﹤0.01% | 4934 |
|
|
2021
Q1 | $196K | Sell |
5,566
-8,651
| -61% | -$319K | ﹤0.01% | 5055 |
|
|
2020
Q4 | $533K | Sell |
14,217
-23,931
| -63% | -$870K | ﹤0.01% | 3205 |
|
|
2020
Q3 | $1.27M | Buy |
+38,148
| New | +$1.11M | ﹤0.01% | 1976 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | – | – | 5536 |
|
|
2018
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5592 |
|
|
2018
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5751 |
|
|
2018
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 5601 |
|
|
2018
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 5453 |
|
|
2017
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5365 |
|
|
2017
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5297 |
|
|
2017
Q2 | $0 | Sell |
2
-600
| -100% | -$12.3K | ﹤0.01% | 5227 |
|
|
2017
Q1 | $14K | Sell |
602
-655
| -52% | -$14.3K | ﹤0.01% | 4023 |
|
|
2016
Q4 | $22K | Sell |
1,257
-421
| -25% | -$8.74K | ﹤0.01% | 3670 |
|
|
2016
Q3 | $22K | Sell |
1,678
-343
| -17% | -$4.04K | ﹤0.01% | 3747 |
|
|
2016
Q2 | $19K | Hold |
2,021
| – | – | ﹤0.01% | 3825 |
|
|
2016
Q1 | $20K | Sell |
2,021
-309
| -13% | -$2.75K | ﹤0.01% | 3751 |
|
|
2015
Q4 | $24K | Sell |
2,330
-50
| -2% | -$517 | ﹤0.01% | 3830 |
|
|
2015
Q3 | $31K | Sell |
2,380
-97
| -4% | -$2.44K | ﹤0.01% | 3820 |
|
|
2015
Q2 | $77K | Sell |
2,477
-60
| -2% | -$2.02K | ﹤0.01% | 3264 |
|
|
2015
Q1 | $91K | Sell |
2,537
-747
| -23% | -$31.5K | ﹤0.01% | 2961 |
|
|
2014
Q4 | $131K | Buy |
3,284
+1,287
| +64% | +$56.5K | ﹤0.01% | 2641 |
|
|
2014
Q3 | $100K | Buy |
+1,997
| New | +$115K | ﹤0.01% | 2989 |
|
|
2014
Q2 | – | Sell |
-1,488
| Closed | -$103K | – | 5584 |
|
|
2014
Q1 | $122K | Buy |
1,488
+48
| +3% | +$4.37K | ﹤0.01% | 2894 |
|
|
2013
Q4 | $98K | Buy |
1,440
+38
| +3% | +$2.78K | ﹤0.01% | 3059 |
|
|
2013
Q3 | $132K | Sell |
1,402
-538
| -28% | -$70K | ﹤0.01% | 2769 |
|
|
2013
Q2 | $243K | Buy |
+1,940
| New | +$202K | 0.01% | 1990 |
|
Other funds holding ALBO
Group One Trading's ALBO Position: Q1 2023 in Review
Group One Trading sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 773 shares — an estimated $16.7K sold.
Group One Trading first reported a position in ALBO in Q2 2013 and held it in 32 quarters. The position peaked at $1.27M in Q3 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Group One Trading reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 773 Albireo Pharma Inc shares in Q1 2023, an estimated $16.7K.
- Group One Trading first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 32 quarters.
- Group One Trading's Albireo Pharma Inc position peaked at $1.27M in Q3 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.